68 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
14 Nov 23
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
4:36pm
environment. These additional funds extend our cash runway into calendar 3Q 2024.”
Business Update
Pharmaceutical Development Programs
Neurodegenerative
424B3
INM
InMed Pharmaceuticals Inc
13 Nov 23
Prospectus supplement
5:05pm
and operations;
The outlook of our business and the global economic and geopolitical conditions; and
The competitive environment in which we … in the documents incorporated herein by reference. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from
8-K
EX-10.1
fsqh cry1larrgac7
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-99.1
hdrgxpgu54yvgcqnwp
24 Jul 23
Regulation FD Disclosure
4:26pm
424B3
cu8e r62kbvopfyf
15 Dec 22
Prospectus supplement
11:42am
8-K
nd4hs9fuo88xtit
12 Dec 22
Changes in Registrant's Certifying Accountant
8:14pm
8-K
EX-10.1
6qy5 tyd1a
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
424B3
yfcy6pp3
19 Oct 22
Prospectus supplement
6:10am